Latest Market News

Activeport signs GOIP Globalnet to its Global Edge network, marking the third international carrier deal in a week and reinforcing its strategy for recurring revenue growth.

Harris Technology (ASX: HT8) reported a 29% sales increase for FY26, driven by its refurbished technology division now contributing 58% of revenue and delivering higher margins. The company also secured a strategic equity conversion from FSP Technology, reinforcing its growth trajectory.

Weebit Nano has lifted its FY 2026 revenue forecast by over 12%, citing growth in customer projects ahead of its full-year results.

Argent Minerals has upgraded its Kempfield silver resource to 142.8 million ounces silver equivalent, reinforcing the project’s scale and quality amid ongoing 2026 drilling campaigns targeting resource expansion and early production pathways.

FBR has locked in a binding agreement for an initial $900,000 convertible note issue, with options to raise up to $3.87 million subject to shareholder approval and other conditions. The funds will support general working capital as the company explores a confidential acquisition opportunity.

Advance ZincTek expects a 13% increase in unaudited profit before tax for FY26, driven by a 12.65% rise in sales revenue amid growing global enquiries.

VanEck Investments Limited has issued a comprehensive Replacement Product Disclosure Statement for its suite of 27 ETFs on the ASX, updating investment strategies, fee structures, risk factors, and operational details.

WAM Income Maximiser has posted a 19.2% investment portfolio gain for the year ended June 2026, outperforming its benchmark by 13.4% with notably lower volatility, while increasing fully franked dividends to an annualised yield of 6.9%.

Actinogen Medical’s phase 2 trial of Xanamem in major depressive disorder with cognitive impairment reveals meaningful antidepressant effects, published in the British Journal of Psychiatry. The drug was safe and well-tolerated but did not improve cognition.

Hydrix has landed a A$3.4 million contract with US-based Remedy Robotics to develop safety-critical software and embedded electronics for the N1 robotic system, marking a major step in its medical robotics ambitions.

Imricor Medical Systems has submitted its final 510(k) devices to the FDA, marking a major step towards commercialising its MRI-guided cardiac catheterisation platform in the US.

AnteoTech has secured independent validation for its Ultranode™ 95 silicon anode in commercial drone battery cells, launched a new battery additive, and strengthened its cash position with a A$10 million capital raise.